Trinity Biotech Closes Offering of $115m of 4pc Exchangeable Senior Notes due 2045 by wheelel23 | Apr 9, 2015 | Press Releases | 0 comments Submit a Comment Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website